Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;25(6):567-610.
doi: 10.1089/thy.2014.0335.

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma

Samuel A Wells Jr  1 , Sylvia L Asa  2 , Henning Dralle  3 , Rossella Elisei  4 , Douglas B Evans  5 , Robert F Gagel  6 , Nancy Lee  7 , Andreas Machens  3 , Jeffrey F Moley  8 , Furio Pacini  9 , Friedhelm Raue  10 , Karin Frank-Raue  10 , Bruce Robinson  11 , M Sara Rosenthal  12 , Massimo Santoro  13 , Martin Schlumberger  14 , Manisha Shah  15 , Steven G Waguespack  6 ; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma
Affiliations
Review

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma

Samuel A Wells Jr et al. Thyroid. 2015 Jun.

Abstract

Introduction: The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association.

Methods: The Task Force identified relevant articles using a systematic PubMed search, supplemented with additional published materials, and then created evidence-based recommendations, which were set in categories using criteria adapted from the United States Preventive Services Task Force Agency for Healthcare Research and Quality. The original guidelines provided abundant source material and an excellent organizational structure that served as the basis for the current revised document.

Results: The revised guidelines are focused primarily on the diagnosis and treatment of patients with sporadic medullary thyroid carcinoma (MTC) and hereditary MTC.

Conclusions: The Task Force developed 67 evidence-based recommendations to assist clinicians in the care of patients with MTC. The Task Force considers the recommendations to represent current, rational, and optimal medical practice.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
Management of patients with a thyroid nodule and histological diagnosis of medullary thyroid carcinoma. ADX, adrenalectomy; Ctn, calcitonin; CEA, carcinoembryonic antigen; EBRT, external beam radiotherapy; FNA, fine-needle aspiration; HPTH, hyperparathyroidism; LND, lymph node dissection; MTC, medullary thyroid carcinoma; M, metastatic MTC; PHEO, pheochromocytoma; RET, REarranged during Transfection; TKI, tyrosine kinase inhibitor; TTX, total thyroidectomy; US, ultrasound.
<b>FIG. 2.</b>
FIG. 2.
Management of patients with a RET germline mutation detected on genetic screening. ATA, American Thyroid Association risk categories for aggressive medullary thyroid carcinoma (MTC) (HST, highest risk, H, high risk, MOD, moderate risk); Ctn, calcitonin; CEA, carcinoembryonic antigen; HPTH, hyperparathyroidism; PHEO, pheochromocytoma; RET, REarranged during Transfection; TTX, total thyroidectomy; US, ultrasound.
<b>FIG. 3.</b>
FIG. 3.
Management of patients following thyroidectomy for persistent or recurrent medullary thyroid carcinoma. Ctn, calcitonin; CEA, carcinoembryonic antigen; EBRT, external beam radiotherapy; MTC, medullary thyroid carcinoma; TFTs, thyroid function tests; TSH, thyrotropin; TKI, tyrosine kinase inhibitor; TTX, total thyroidectomy; US, ultrasound.
See this image and copyright information in PMC

Comment in

References

    1. Cancer of the Thyroid Invasive: Trends in SEER Incidence and U.S. Mortality Using the Joinpoint Regression Program, 1975–2011(SEER) Stat version 8.1.2 Rate Session. (Access the SEER 18 database at www.seer.cancer.gov). Incidence - SEER 18 Regs Research Data+Hurricane Katrina Impacted Louisiana Cases, Nov 2012 Sub (2000–2010)<Katrina/Rita Population Adjustment>- Linked To County Attributes - Total U.S., 1969–2011 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission
    1. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA, Jr, Marx SJ. 2001. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671 - PubMed
    1. Tuttle RM, Ball DW, Byrd D, Daniels GH, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA, Jr, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ. 2010. Medullary carcinoma. J Natl Compr Canc Netw 8:512–530 - PubMed
    1. Chen H, Sippel RS, O'Dorisio MS, Vinik AI, Lloyd RV, Pacak K. 2010. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39:775–783 - PMC - PubMed
    1. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA., Jr 2009. Medullary thyroid cancer: management guidelines ofthe American Thyroid Association. Thyroid 19:565–612 - PubMed

MeSH terms

Substances

Supplementary concepts